vimarsana.com
Home
Live Updates
Cannara Biotech Reports Q2 2024 Financial Results : vimarsan
Cannara Biotech Reports Q2 2024 Financial Results : vimarsan
Cannara Biotech Reports Q2 2024 Financial Results
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase.
Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...
Related Keywords
Montreal ,
Quebec ,
Canada ,
Valleyfield ,
Newfoundland ,
Germany ,
Linx ,
Baden Wüberg ,
United Kingdom ,
Israel ,
Canadian ,
British ,
Israeli ,
Zohar Krivorot ,
Nicholas Sosiak ,
Innovative Strain Development ,
Manitoba Liquor Lotteries Corporation ,
National Instrument ,
Nova Scotia Liquor Corporation ,
Israeli Ministry Of Health ,
Venture Exchange ,
Cannara Biotech Inc ,
International Financial Reporting Standards ,
Regulation Services Provider ,
Company Board Of Directors ,
Manitoba Liquor ,
Lotteries Corporation ,
Segment Measures ,
Market Share Growth Across Key Regions ,
Strain Development ,
Neon Sunshine ,
Guava Jam ,
Valleyfield Facility ,
Valleyfield Site ,
Across Key Canadian Markets ,
From December ,
British Columbia ,
Enters East Coast Recreational Market With ,
Tribal Cuban Linx ,
Changes Boost Global Cannabis Market ,
Effective April ,
Israeli Ministry ,
Weed Crawler ,
Headset Data ,
Distribution Insights ,
Assembly General Meeting ,
Free Cash ,
Cannara Biotech ,
Statement Regarding ,